COMPPARE – Proton and Photon Radiation in Prostate Cancer

Welcome to COMPPARE

A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer. Patient enrollment in COMPPARE closed October 31, 2022.

Visit Our newsROOM

Red Journal Publishes COMPPARE Study Article

Category: Homepage Feature

Read the abstract for “Can Engagement aid in design and accrual on Clinical Trials? Observations from COMPPARE – A Prospective Comparison of Outcomes…

Can Engagement aid in design and accrual on Clinical Trials? Observations from COMPPARE – A Prospective Comparison of Outcomes with Proton and Photon Radiation in Prostate Cancer

Early COMPPARE Results Presented at ASCO

Category: Homepage Feature

Two-year findings were discussed at ASCO in Chicago on May 31, but assessing long-term comparative outcomes like disease control, late toxicity and…

“More follow-up is needed to assess important long-term outcomes like disease control, late effects and development of secondary cancers,” Dr. Mendenhall said.

For participants

Meet the Team

COMPPARE clinicians, researchers, patients, and other stakeholders

Who we are

For Healthcare providers

ClinicalTrials.gov

Privately and publicly funded clinical studies conducted around the world.

VTOC Login

Medical Team sign-in page